Thor Medical
Be the first to follow this company
Thor Medical is a pharmaceutical company. The company specializes in the development of antibody drugs for the treatment of hematological cancer. The greatest specialization is found in precision therapy used in the clinical phase. Other diseases that are treated are non-Hodgkin's lymphoma (NHL). The company was founded in 2009 and is headquartered in Oslo, Norway.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
Oslo Børs
TRMED
Daily low / high price
-
Market cap
-
Turnover
-
Volume
-
Financial calendar
Interim report
30.08.2024
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Scatec Innovation AS | 24.5 % | 24.5 % |
Roht Invest AS | 6.9 % | 6.9 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
TRMED: New share capital registered
TRMED: Share option grant
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools